Vidyya Medical News Service
*
Volume 5 Issue 154 Published - 14:00 UTC 08:00 EST 3-June-2003 Next Update - 14:00 UTC 08:00 EST 4-June-2003
little clear gif used for spacer
.
*

The latest research explores the possible causes of violent behavior
Flawed brain chemistry, brain damage, genetic defects, an unhealthy psychological environment take them individually or mix them together and you may have the right ingredients for violent behavior, reports a variety of researchers.  more

*
Donor immune cells attack metastatic breast cancer
In patients with metastatic breast cancer, immune cells from a genetically matched donor can attack and shrink tumors, researchers from the National Cancer Institute (NCI) announced today at the Annual Meeting of the American Society of Clinical Oncology in Chicago. This is the first time researchers have clearly demonstrated this type of immune response, known as a graft-versus-tumor effect, acting against breast cancer.  more

 


*
Rare breast cancer: Men don't recognize male breast cancer until it's too late
Breast cancer in men is usually detected when the tumors are bigger, have spread and may be more aggressive, compared to diagnosis of the disease in women, concludes the largest study ever conducted of male breast cancer. The findings, presented at the annual meeting of the American Society of Clinical Oncology, suggest both that breast cancer in men may have some important biological differences from the female disease, and that men are seemingly less aware than they should be that they can develop breast cancer.  more

*
Accurate diagnosis of early stage uterine cancer requires lymph-node check
Research at Washington University School of Medicine in St. Louis suggests that the accurate diagnosis of early stage endometrial cancer requires that the abdominal lymph nodes always be removed and checked for signs of cancer. The recommendation extends even to women with tumors that seem to have the smallest risk of spread.  more

*
New chemotherapy combination lengthens survival in late stage stomach cancer patients
Adding docetaxel to the most commonly used combination chemotherapy improved tumor regression rate, delayed tumor growth and prolonged survival for patients with advanced stomach cancer, according to interim results of a Phase III international clinical trial presented at the annual meeting of the American Society of Clinical Oncology.  more

 
little clear gif used for a space